Differentiation Induction in Acute Myelogenous Leukemia

NCT00175812 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: all-trans retinoic acid (ATRA)
DRUG: Valproic acid
DRUG: Theophyllin

Sponsor

University of Bergen